Autopsy report · NCT02711462

Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The study was prematurely terminated on 06 October 2016 due to the potential risk of further dosing in healthy subjects”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 6 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Pfizer
Sponsor type: Industry
Conditions: Healthy
Interventions: PF-06687234; Placebo
Participants: 10
Sites: 1
Countries: Belgium

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.